Expected to strengthen its pace at a CAGR of 4%, the global electrocautery enhanced delivery system market is likely to be valued at US$ 2.9 billion in 2023, and will eventually reach a valuation of US$ 4.3 billion in 2033. Often used interchangeably, electrosurgery and electrocautery are unique approaches. While electrocautery only facilitates coagulation, the former facilitates both cuttings as well as coagulation. Electrocautery, often also known as thermal cautery, uses a connected device with a heating element. While the current never passes through the patient’s body, a passive heat transfer helps penetrate and access the organs.
Electrocauterization is primarily deployed to remove unwanted or harmful tissue, as well as to burn and seal blood vessels. Electrocautery has proven to be a highly safe and effective procedure, helping reduce or stop bleeding during or post-surgery. Hence, the uptake of electrocautery-enhanced delivery systems is rising at a rapid pace, paving way for numerous developments with respect to equipment technology and surgical procedures.
Globally, the electrocautery enhanced delivery system market is gaining major traction, attributed to prolific developments in cancer treatment. As of 2020, there were nearly 10 million fatalities due to cancer, as per the World Health Organization. Each year, around 400,000 children develop cancer. Consequently, government initiatives aimed at educating and preventing the onset of the disease have gained momentum. This has also led to an increase in budgetary allocation towards cancer eradication.
In recent times, the best approach to reducing cancer burden is the detection of suspected malignancies even before the disease takes root. For this, penetration of the human tissue is important, and electrocautery is the most suitable approach in doing so. The procedure can also be used in the early stages of the disease. Recent evidence suggests that electrocautery enhanced delivery systems are specially used for treating non-small cell lung cancers. The procedure is one part of endobronchial therapies. These are often highly effective against very early-stage lung cancers.
Given the extensive applications of these systems, a number of manufacturers are establishing bases across various regions. Olympus Corporation, for example, is a prominent supplier and manufacturer of bronchoscopic electrocautery devices. These include electrodes, knives, snares, and hot biopsy forceps, along with other electrocautery accessories. These products are reusable. Likewise, Boston Scientific offers the AXIOSTM Stent and Electrocautery Enhanced Delivery System, which helps physicians manage serious complications arising from pancreatitis via a minimally invasive surgical approach.
Regionally, North America is expected to generate substantial growth opportunities for electrocautery enhanced delivery system providers. Growth is principally attributed to extensive reliance on minimally invasive surgical procedures. Akin to other minimally invasive procedures, electrocautery makes smaller incisions in the body and is usually less risky compared to conventional surgery. Besides North America, Europe and Asia Pacific are also expected to emerge as key investment hotspots, given the rising number of surgical procedures for a wide range of ailments.
| Data Points | Key Statistics |
|---|---|
| Expected Value of Electrocautery Enhanced Delivery Device Market in 2023 | US$ 2.9 billion |
| Projected Value of Electrocautery Enhanced Delivery Device Market in 2033 | US$ 4.3 billion |
| Global Growth Rate (2023 to 2033) | CAGR of 4% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Electrocautery, also called as thermal cautery. This process helps in reducing or stopping of bleeding during surgeries or any injuries which is propelling the growth of the electrocautery enhanced delivery system market.
Furthermore, electrocautery enhanced delivery system is a precision device designed to enable therapeutic endoscopists to conduct the procedure safely and accurately at the bile duct, gall bladder, orpancreaticfluids collection form which is fuelling for the growth of electrocautery enhanced delivery system market.
It is only stent indicated for trans gastric and trans duodenal endoscopic drainage of symptomatic pancreatic pseudocyst which is triggering the electrocautery enhanced delivery system market growth. Moreover, it provides simpler and faster treatment options for patients which is fuelling demand for the growth of electrocautery enhanced delivery system market.
Rise in number of chronic diseases, increase in surgeries, low risk in patient’s treatment, minimal invasive procedures and others that require electrocauterisation are some of the major driving factors that are influencing the electrocautery enhanced delivery system market growth in near future.
Additionally, the availability of a wide range of reusable electrocautery devices and electrodes, with different working temperature are further triggering the electrocautery enhanced delivery system market growth. Furthermore, improved procedural efficiency by reduction of time, by low exposure to X-Ray imaging, reduction of anaesthesia time are favouring the growth of electrocautery enhanced delivery system market.
For instance, physicians manage complex pancreatic surgeries and other through minimal invasive procedure.
Moreover, the electrocautery enhanced delivery system is approved by FDA for endoscopic visualization of pancreatic pseudocysts, pancreatic necrosis, which are of 2 types of pancreatic fluid collections that occur in 5-16 percent of patients with acute pancreatic and 20-40 percent in chronic pancreatic which is also influencing the electrocautery enhanced delivery system market growth during the forecast period.
Along with this, growing demand for cosmetic and plastic surgeries, burn procedures, abdominal lipectomy, tendon repair, mammoplasty and others are emerging as the potential opportunities for the growth of electrocautery enhanced delivery system market during the forecast period.
However, lack of skilled professional, unavailability of supportive infrastructure, lack of awareness, low technology penetration, bacterial contamination of electrode tips are the factors hindering the electrocautery enhanced delivery system market growth in near future.
Principal Consultant
The global electrocautery enhanced delivery system market is anticipated to experience vast growth during the forecast period. Owing to rise in simpler and fast procedural treatment options for patients. Based on the product dispersive electrode segment is dominating the electrocautery enhanced delivery system market due to technological developments in the product.
Based on the end users the hospitals and emergency ambulatory surgical centers are leading the electrocautery enhanced delivery system market due to rise in patient flow, rise in emergency complex procedures, others.
Moreover, in electrocautery there is proper metal probe that is sterilized properly along with temperature controller that does not damage the tissues and surrounding areas which helps in smooth procedure which boosts the electrocautery enhanced delivery system market growth.
Geographically, the electrocautery enhanced delivery system market is segmented into North America, Europe, Latin America, South Asia, East Asia, Oceania, Middle East and Africa. North America is dominating the electrocautery enhanced delivery system market owing to the increase in minimal invasive procedures, availability of skilled professionals, supportive infrastructure, and others.
Europe is second largest contributor to the electrocautery enhanced delivery system market growth due to high awareness of healthcare, increase per capita income expenditure and others.
Asia Pacific is fastest growing in the electrocautery enhanced delivery system market due to rise in geriatric population, rise in awareness about minimal invasive procedures, government initiatives, rise in importance for patient care, focus on more research and development related to technological advancements and others.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Some of the major key players of the electrocautery enhanced delivery system market are Boston Scientific, McKesson Corporation, Symmetry surgical, World precision instruments, Medline Industries, Inc., Medtronic Plc, Erbe Elektromedizian Gmbh, Smith and Nephew Plc, Olympus Corporation and others.
The research report on Electrocautery Enhanced Delivery System presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies.
The research report on Electrocautery Enhanced Delivery System provides analysis and information according to market segments such as geographies, application, and industry.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain.
The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
The global electrocautery enhanced delivery system market is classified on the basis of product, application, end-user and region.
Explore Healthcare Insights
View Reports
Electrocautery Enhanced Delivery System Market
